In conclusion, we validated a new LMF1-deficient mouse model by demonstrating that it recapitulates salient phenotypes of cld mutant mice including neonatal lethality, dyslipidemia and combined lipase deficiency. The gene discussed is SLC26A3; the disease is metabolic syndrome.